Inovio Pharmaceuticals (INO) Insider Trading & Ownership $1.32 +0.01 (+0.38%) As of 09:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inovio Pharmaceuticals (NASDAQ:INO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.30%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$57.18K Get INO Insider Trade Alerts Want to know when executives and insiders are buying or selling Inovio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INO Insider Buying and Selling by Quarter Inovio Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/13/2023David B WeinerDirectorSell40$165.60$6,624.00 2/27/2023David B WeinerDirectorSell81$184.32$14,929.92 8/11/2022David B WeinerDirectorSell82$383.04$31,409.28 7/20/2022Simon X BenitoDirectorSell13$324.00$4,212.00 (Data available from 1/1/2013 forward) INO Insider Trading Activity - Frequently Asked Questions Who is on Inovio Pharmaceuticals' Insider Roster? The list of insiders at Inovio Pharmaceuticals includes David B Weiner, and Simon X Benito. Learn more on insiders at INO. What percentage of Inovio Pharmaceuticals stock is owned by insiders? 2.30% of Inovio Pharmaceuticals stock is owned by insiders. Learn more on INO's insider holdings. Inovio Pharmaceuticals Key ExecutivesDr. Jacqueline E. Shea Ph.D. (Age 58)CEO, President & Director Compensation: $1.13MMr. Peter D. Kies (Age 61)Chief Financial Officer Compensation: $810.2kDr. Laurent M. Humeau Ph.D. (Age 57)Chief Scientific Officer & Chairman of the Scientific Advisory Board Compensation: $794.08kThomas HongManager of Investor RelationsMr. Robert L. Crotty J.D. (Age 50)General Counsel & Chief Compliance Officer Mr. E. J. Brandreth MBASenior Vice President of Quality AssuranceDr. Jeffrey SkolnikSenior Vice President of Clinical DevelopmentMr. Robert J. Juba Jr.Senior Vice President of Biological Manufacturing & Clinical Supply ManagementMr. Stephen Kemmerrer M.B.A.P.E., Senior Vice President of Engineering DevelopmentMr. Shawn D. Bridy M.A.M.B.A., Senior Vice President of Business Development More Insider Trading Tools from MarketBeat Related Companies MRNA Insider Transactions TLSI Insider Transactions PROF Insider Transactions CVRX Insider Transactions KRMD Insider Transactions ELMD Insider Transactions LNSR Insider Transactions PDEX Insider Transactions RCEL Insider Transactions LAKE Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:INO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
